Massachusetts · 194th Legislature (2025-2026) · Proposed Bill
SD 3797: Special Commission on the Public Health Effects of Xylazine Final Report
Introduced Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SD 3797 is a proposed bill introduced in the Massachusetts Senate on March 30, 2026. According to its official title, it concerns: Special Commission on the Public Health Effects of Xylazine Final Report. Primary sponsor: Special Commission on Public Health Effects of Xylazine. Most recent recorded action (March 30, 2026): Placed on file.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Report of the Special Commission on Public Health Effects of Xylazine (pursuant to Section 36 of Chapter 285 of the Acts of 2024) submitting its recommendations and final report on ways to address the public health and safety concerns posed by the proliferation of xylazine as an additive to illicit drugs including, but not limited to, fentanyl
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Special Commission on Public Health Effects of Xylazine | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Placed on file